Shailender Bhatia

Dr. Shailender Bhatia is a Professor in Medical Oncology at the University of Washington (UW) and Fred Hutchinson Cancer Center (FHCC), Seattle, WA. He also serves as the Clinical and Research Director of the Melanoma program. Dr. Bhatia has been engaged in clinical and translational research in the field of skin cancer immunotherapy since 2006 and has a special interest in intra-tumoral, novel targeted immunotherapy trials, cost-effectiveness, and novel dosing strategies. His research has resulted in >125 peer-reviewed manuscripts, including several top-tier journals.